LUNA vs. NOTV, ONMD, BIAF, BASI, AIKI, DKDCA, FOXO, ISPC, PGEN, and NRC
Should you be buying Luna Innovations stock or one of its competitors? The main competitors of Luna Innovations include Inotiv (NOTV), OneMedNet (ONMD), bioAffinity Technologies (BIAF), Bioanalytical Systems (BASI), AIkido Pharma (AIKI), Data Knights Acquisition (DKDCA), FOXO Technologies (FOXO), iSpecimen (ISPC), Precigen (PGEN), and National Research (NRC).
Inotiv (NASDAQ:NOTV) and Luna Innovations (NASDAQ:LUNA) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their analyst recommendations, community ranking, valuation, institutional ownership, dividends, media sentiment, profitability, earnings and risk.
Inotiv has a beta of 3.37, meaning that its share price is 237% more volatile than the S&P 500. Comparatively, Luna Innovations has a beta of 1.4, meaning that its share price is 40% more volatile than the S&P 500.
In the previous week, Luna Innovations had 17 more articles in the media than Inotiv. MarketBeat recorded 18 mentions for Luna Innovations and 1 mentions for Inotiv. Luna Innovations' average media sentiment score of 1.26 beat Inotiv's score of 0.35 indicating that Inotiv is being referred to more favorably in the media.
Luna Innovations has a net margin of -1.82% compared to Luna Innovations' net margin of -12.90%. Inotiv's return on equity of 3.61% beat Luna Innovations' return on equity.
Luna Innovations has lower revenue, but higher earnings than Inotiv. Luna Innovations is trading at a lower price-to-earnings ratio than Inotiv, indicating that it is currently the more affordable of the two stocks.
Inotiv currently has a consensus price target of $6.19, suggesting a potential upside of 230.88%. Luna Innovations has a consensus price target of $10.00, suggesting a potential upside of 199.40%. Given Luna Innovations' higher possible upside, equities research analysts clearly believe Inotiv is more favorable than Luna Innovations.
Luna Innovations received 181 more outperform votes than Inotiv when rated by MarketBeat users. Likewise, 61.23% of users gave Luna Innovations an outperform vote while only 47.37% of users gave Inotiv an outperform vote.
18.2% of Inotiv shares are held by institutional investors. Comparatively, 87.5% of Luna Innovations shares are held by institutional investors. 5.8% of Inotiv shares are held by company insiders. Comparatively, 7.6% of Luna Innovations shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.
Summary
Luna Innovations beats Inotiv on 13 of the 18 factors compared between the two stocks.
Get Luna Innovations News Delivered to You Automatically
Sign up to receive the latest news and ratings for LUNA and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding LUNA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Luna Innovations Competitors List
Related Companies and Tools
